Edgewise Therapeutics CMO Joanne M. Donovan disposes of USD 411,192 in common shares

• Edgewise Therapeutics CMO Joanne M. Donovan reported RSU vesting on Aug. 12, 2026, adding 12,812 common shares.
• Sold 6,522 common shares on Aug. 12-13 at average prices of $43.41-$44.52.
• Directly owned 8,625 common shares following the transactions.
• Reported new equity awards on Aug. 12, 2026, including 32,500 restricted stock units and options covering 65,000 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edgewise Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001644087-26-000005), on August 14, 2026, and is solely responsible for the information contained therein.